A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
Condition:   Primary Membranous Nephropathy Interventions:   Drug: Zanubrutinib;   Drug: Tacrolimus Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials

Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
Condition:   Sjogren Syndrome With Other Organ Involvement Interventions:   Drug: Prednisolone;   Drug: Tacrolimus Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2023 Category: Research Source Type: clinical trials